Tag Archives: Analyst Opinion of Chemours

Is It A Dog? A Diamond In The Rough? Wall Street Weighs In On DuPont’s Chemours Spinoff

One of the attractions of spinoffs is that they tend to be underfollowed companies out of the gate. Of course, that isn’t always the case and DuPont’s (DD) recent Chemours (CC) spin has sure gotten plenty of attention although most of it hasn’t been so great. Wall Street’s opinions started rolling in about a week prior to theā€¦ Read More »